Frova comes as a tablet to be taken by mouth with fluids. It is important to use it exactly as prescribed by your doctor and to understand its specific usage for acute migraine treatment.

• Timing of Dose: Take Frova at the first sign of a migraine headache. It is not meant to be taken before a migraine starts (as a preventive) or for other types of headaches.
• Initial Dose: The recommended initial dose is a single 2.5 mg tablet.
• Second Dose (if needed): If your migraine symptoms improve after the first dose but then return, you may take a second tablet. However, there must be an interval of at least 2 hours between doses.
• Maximum Dose: Do not take more than 3 tablets (7.5 mg total) in any 24-hour period.
• Non-Response to First Dose: There is no evidence that a second dose of Frova is effective in patients who do not respond to the first dose for the same headache. If your first dose does not provide relief, consult your doctor before taking another dose for that same migraine attack.
• Limitations of Use: The safety of treating an average of more than 4 migraine attacks in a 30-day period has not been established.
• Swallowing: Swallow the tablet whole with water.

Store Frova tablets at room temperature, protected from light and moisture, and keep them out of reach of children.

Frova (frovatriptan) works by affecting specific receptors in the brain to alleviate migraine symptoms.

• Serotonin Receptor Agonist: Frovatriptan acts as an agonist at serotonin (5-HT1B/1D) receptors. These receptors are found on blood vessels around the brain and on nerve endings.
• Blood Vessel Narrowing: By stimulating these receptors, Frova causes the blood vessels around the brain, which are often dilated during a migraine attack, to narrow. This vasoconstriction helps to reduce the throbbing pain associated with migraines.
• Pain Signal Blocking: It also helps to block pain signals from being transmitted to the brain.
• Reduction of Migraine-Causing Substances: Additionally, Frova reduces the release of certain natural substances in the body that can trigger headache pain, nausea, sensitivity to light (photophobia), and sensitivity to sound (phonophobia)—common symptoms of migraine.

Frova only works to treat a migraine headache that has already begun; it does not prevent future migraines or reduce the frequency of attacks.

Like all medications, Frova can cause side effects. Most side effects are generally mild to moderate and temporary.

• Common Side Effects (may affect up to 1 in 10 people):
  • Dizziness, lightheadedness
  • Fatigue, tiredness
  • Nausea, dry mouth, indigestion, abdominal pain
  • Paresthesia (tingling, numbness, or pins-and-needles sensation, often in fingers or toes)
  • Headache (can be a recurrence or medication overuse headache if used excessively)
  • Flushing (feeling of warmth)
  • Chest discomfort, tightness in the throat, neck, or jaw (usually non-cardiac in origin, but a cardiac evaluation may be needed in high-risk patients)
  • Increased sweating
  • Insomnia
• Less Common / Serious Side Effects (Seek immediate medical attention if any of these occur):
  • Serious Cardiovascular Events: Rare but serious heart-related events, including heart attack, abnormal heart rhythms (arrhythmias), or coronary artery vasospasm (narrowing of heart arteries). Symptoms may include severe chest pain (spreading to jaw/arm), shortness of breath, or sweating.
  • Serotonin Syndrome: As mentioned in “Interactions,” symptoms like agitation, confusion, rapid heart rate, fever, muscle stiffness, twitching, shivering, or severe diarrhea.
  • Stroke or Cerebrovascular Events: Sudden numbness or weakness, confusion, difficulty speaking, vision changes, or loss of balance.
  • Gastrointestinal Ischemia: Sudden or severe stomach pain, bloody diarrhea (due to decreased blood flow to the intestines).
  • Allergic Reactions: Rash, hives, swelling of the face, lips, tongue, or throat, or difficulty breathing.
  • Increased Blood Pressure: Frova can cause a temporary increase in blood pressure.

If you experience any concerning or severe side effects, stop using Frova and seek medical attention immediately.

Frova should be used with caution, and certain medical conditions or concurrent medications can increase the risk of serious side effects.

• Cardiovascular Disease Risk: Frova is contraindicated in patients with a history of ischemic heart disease (e.g., angina, heart attack), Prinzmetal’s angina, uncontrolled high blood pressure, or other serious cardiovascular conditions. A cardiovascular evaluation is recommended for triptan-naïve patients with multiple cardiovascular risk factors (e.g., increased age, diabetes, hypertension, smoking, obesity, strong family history of coronary artery disease) before starting Frova.
• Cerebrovascular Disease: Frova is contraindicated in patients with a history of stroke or transient ischemic attack (TIA). It should not be used for basilar or hemiplegic migraines due to increased stroke risk.
• Serotonin Syndrome Risk: Be aware of the risk of serotonin syndrome, especially when taking other serotonergic drugs (see Section 3).
• Peripheral Vascular Disease: Use with caution in patients with peripheral vascular disease (e.g., Raynaud’s syndrome), as triptans can worsen vasoconstriction.
• Liver Impairment: Use with caution in patients with severe liver impairment, as Frova is metabolized by the liver.
• Medication Overuse Headache (MOH): Excessive use of acute migraine medications, including triptans like Frova, can lead to chronic daily headaches or a worsening of migraine frequency (MOH).
• Pregnancy and Breastfeeding: Frova is generally not recommended during pregnancy or breastfeeding unless clearly necessary, as safety has not been fully established. Breastfeeding should be avoided for 24 hours after taking Frova.
• Allergies: Do not use if you are allergic to frovatriptan or any of its ingredients.
• Children and Adolescents: The safety and effectiveness of Frova have not been established in patients younger than 18 years of age.

Your doctor will assess your medical history and risk factors before prescribing Frova.

It is crucial to inform your doctor about all medications you are taking, including prescription, over-the-counter drugs, herbal products, and supplements, as Frova can interact with various substances, potentially leading to serious side effects.

• Other Triptans (5-HT1 Agonists): Do not use Frova within 24 hours of taking other triptans (e.g., sumatriptan, zolmitriptan, eletriptan, naratriptan, almotriptan) due to the risk of additive vasospastic effects.
• Ergot-Containing Drugs: Avoid using Frova within 24 hours of ergotamine-containing or ergot-type medications (e.g., dihydroergotamine, methysergide) as these can also cause prolonged vasoconstriction.
• SSRIs / SNRIs and Serotonin Syndrome: Co-administration with Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin Norepinephrine Reuptake Inhibitors (SNRIs), tricyclic antidepressants (TCAs), MAO inhibitors, or other serotonergic drugs can lead to a potentially life-threatening condition called serotonin syndrome. Symptoms can include agitation, hallucinations, rapid heartbeat, fever, overactive reflexes, nausea, vomiting, and diarrhea.
• Monoamine Oxidase Inhibitors (MAOIs): Frova should not be used within 2 weeks of discontinuing an MAOI, as MAOIs can increase the levels of frovatriptan in the body.
• Oral Contraceptives: Oral contraceptives may increase frovatriptan levels, but dose adjustment is generally not necessary.
• Propranolol: Propranolol can increase frovatriptan levels.

Always provide a comprehensive medication list to your healthcare provider to assess potential interactions.

The dosage of Frova is specifically for the acute treatment of migraine headaches in adults.

• Standard Dose: A single 2.5 mg tablet taken orally with fluids at the onset of a migraine headache.
• Repeat Dose: If the migraine recurs after initial relief, a second 2.5 mg tablet may be taken after an interval of at least 2 hours from the first dose.
• Maximum Daily Dose: Do not exceed a total dose of 7.5 mg (3 tablets) in any 24-hour period.
• No Response to First Dose: If the first dose does not provide any relief, do not take a second dose for the same migraine attack without consulting your healthcare provider.
• Long-Term Use: The safety of treating more than 4 migraine attacks in a 30-day period has not been established.
• Renal/Hepatic Impairment: No dose adjustment is generally recommended for patients with mild to moderate renal or hepatic impairment. However, use with caution in severe hepatic impairment.

Always follow your doctor’s exact instructions regarding the dosage and administration of Frova.

Frova (frovatriptan) is a prescription-only medication. It cannot be obtained without a valid prescription from a licensed healthcare professional.

• Diagnosis Required: Frova is only prescribed after a clear diagnosis of migraine has been established by a physician. It is not an ordinary pain reliever and should only be used for migraine headaches.
• Medical Evaluation: Due to potential serious side effects, particularly cardiovascular risks, a thorough medical evaluation is necessary before a doctor prescribes Frova. This may include assessing risk factors for heart disease.
• Patient Counseling: Patients will receive detailed instructions on how to use Frova, including proper dosing, when to take it, and important warnings about potential side effects and interactions.
• Contraindications: Its use is contraindicated in patients with certain pre-existing conditions (e.g., ischemic heart disease, stroke, uncontrolled hypertension), necessitating careful medical screening.

Therefore, Frova is always prescribed and managed under the strict supervision of a qualified healthcare professional.

What is Frova used for? Treatment of acute migraine attacks (with or without aura) in adults

2. What is the active ingredient? Frovatriptan succinate

3. What drug class does it belong to? Triptans (serotonin receptor agonists)

4. Is Frova a controlled substance? No

5. Is Frova available in generic form? Yes

6. How is Frova administered? Orally, as tablets

7. What strengths are available? 2.5 mg tablets

8. What is the usual adult dosage? 2.5 mg at onset of migraine; may repeat after 2 hours if needed (max 7.5 mg/24 hrs)

9. Can it be used in children? Not approved for pediatric use

10. What are common side effects? Dizziness, fatigue, flushing, dry mouth

11. Can it cause serious reactions? Yes—cardiac events (angina, arrhythmia), serotonin syndrome, stroke (rare)

12. Is Frova safe during pregnancy? Use only if benefits outweigh risks; consult a healthcare provider

13. Is a prescription required? Yes

14. Is Frova available in Pakistan? Not widely; other triptans (sumatriptan, rizatriptan) are more common

15. How should it be taken? At first sign of migraine; not for prevention

16. What precautions should be taken during use? Avoid in patients with cardiovascular disease, uncontrolled hypertension, or history of stroke

17. What are contraindications? Ischemic heart disease, cerebrovascular disease, peripheral vascular disease, severe hepatic impairment

18. What monitoring is needed during use? Cardiac evaluation in high-risk patients; monitor for serotonin syndrome if combined with SSRIs/SNRIs

19. Can Frova be combined with other migraine medications? Yes—may be used with NSAIDs or preventive agents, but avoid other triptans/ergotamines within 24 hrs

20. What are similar drugs? Sumatriptan, rizatriptan, zolmitriptan, naratriptan